K Number
K101692
Device Name
PATIENT MONITOR
Date Cleared
2011-06-28

(377 days)

Regulation Number
870.1025
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The CMS8000 Patient Monitor is intended to be used for monitoring, displaying, reviewing, storing and alarming of multiple physiological parameters including ECG, Heart Rate (HR), Respiration Rate (RESP), Non-invasive Blood Pressure (NIBP), Invasive Blood Pressure (IBP), carbon dioxide (CO2), and Temperature (TEMP) of adult, pediatric and neonatal patient. The Pulse Oxygen Saturation (SpO2) and Pulse Rate (PR) are intended use for adult and pediatric patient. The monitor is to be used in healthcare facilities by clinical physicians or appropriate medical staff under the direction of physicians. It is not intended for helicopter transport or hospital ambulance.
Device Description
The proposed device, CMS8000 Patient Monitor is intended to be used for monitoring, displaying, reviewing, storing and alarming of multiple physiological parameters. It has the physical and technical alarming function with audio and visual alarming, The device can driven by AC or DC power supply.
More Information

No
The summary describes a standard patient monitor with no mention of AI or ML capabilities.

No
The device is described as a patient monitor intended for monitoring, displaying, reviewing, storing, and alarming physiological parameters, not for providing therapeutic treatment.

No

The device is described as a "Patient Monitor" intended for "monitoring, displaying, reviewing, storing and alarming of multiple physiological parameters." It provides measurements of physiological parameters but does not make a diagnosis or assist in making a diagnosis.

No

The device description explicitly states it is a "Patient Monitor" and mentions physical and technical alarming functions, AC/DC power supply, and performance testing involving clinical and bench testing of SpO2 and NIBP measurement functions, all of which indicate a hardware component.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use clearly states that the CMS8000 Patient Monitor is for monitoring, displaying, reviewing, storing, and alarming of physiological parameters (ECG, HR, RESP, NIBP, IBP, CO2, TEMP, SpO2, PR). These are measurements taken directly from the patient's body, not from samples of bodily fluids or tissues in vitro (outside the body).
  • Device Description: The description reinforces that it monitors physiological parameters and has alarming functions. There is no mention of analyzing samples.
  • Lack of IVD Characteristics: The document does not mention any of the typical characteristics of an IVD, such as:
    • Analyzing blood, urine, tissue, or other bodily fluids.
    • Using reagents or assays.
    • Providing diagnostic information based on laboratory analysis.

IVD devices are specifically designed to perform tests on samples taken from the human body to provide information for the diagnosis, monitoring, or treatment of diseases or conditions. The CMS8000 Patient Monitor is a device for monitoring vital signs directly from the patient.

N/A

Intended Use / Indications for Use

The CMS8000 Patient Monitor is intended to be used for monitoring, displaying, reviewing, storing and alarming of multiple physiological parameters including ECG, Heart Rate (HR), Respiration Rate (RESP), Non-invasive Blood Pressure (NIBP), Invasive Blood Pressure (IBP), carbon dioxide (CO2), and Temperature (TEMP) of adult, pediatric and neonatal patient. The Pulse Oxygen Saturation (SpO2) and Pulse Rate (PR) are intended use for adult and pediatric patient.
The monitor is to be used in healthcare facilities by clinical physicians or appropriate medical staff under the direction of physicians. It is not intended for helicopter transport or hospital ambulance.

Product codes

MHX, DSI, MLD, DRT, DXN, DSK, DQA, BZQ, CCK, FLL

Device Description

The proposed device, CMS8000 Patient Monitor is intended to be used for monitoring, displaying, reviewing, storing and alarming of multiple physiological parameters. It has the physical and technical alarming function with audio and visual alarming, The device can driven by AC or DC power supply.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

adult, pediatric and neonatal patient.

Intended User / Care Setting

healthcare facilities by clinical physicians or appropriate medical staff under the direction of physicians.

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Performance testing including clinical and bench testing was conducted to validate and verify that the proposed device, the Patient Monitors met all design specifications. The proposed device, General Patient Monitors, has conducted clinical test into performance verification of SpO2 and NIBP measure function according with the standard of ISO 9919 and AAMI SP10. The proposed device, General Patient Monitors, has conducted the test according with the following standard to demonstrate the effectiveness and safety performance of device. IEC 60601-1, Medical Electrical Equipment - Part 1: General Requirements for Safety, 1988; Amendment 1, 1991-11, Amendment 2, 1995. IEC 60601-1-2:2007 Medical Electrical Equipment - Part 1-2: General Requirements for Safety - Collateral Standard: Electromagnetic Compatibility - Requirements and Tests. AAMI / ANSI EC13:2002/(R) 2007, Cardiac monitors, heart rate meters, and alarms. ISO 9919:2005: Medical electrical equipment - Particular requirements for the basic safety and essential performance of pulse oximeter equipment for medical use. AAMI SP10:2002, Manual, electronic or automated sphygmomanometers. IEC 60601-2-34:2000, Medical electrical equipment - Part 2-34: Particular requirements for the safety, including essential performance, of invasive blood pressure monitoring equipment. ISO 21647:2004, Medical electrical equipment - Particular requirements for the basic safety and essential performance of respiratory gas monitors.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K072346

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 870.1025 Arrhythmia detector and alarm (including ST-segment measurement and alarm).

(a)
Identification. The arrhythmia detector and alarm device monitors an electrocardiogram and is designed to produce a visible or audible signal or alarm when atrial or ventricular arrhythmia, such as premature contraction or ventricular fibrillation, occurs.(b)
Classification. Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Arrhythmia Detector and Alarm” will serve as the special control. See § 870.1 for the availability of this guidance document.

0

JUN 28 2011

Premarket Notification
Section 510(k) Submission
Section III 510(k) Submission
Section III 510(k) Summary

Section III 510(k) Summary

This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92.

Date of SubmissionJun 8th, 2010
SponsorEstablishment Registration No.: 3006979678
Contec Medical Systems Co., Ltd, No. 24, West Huanghe Road,Qinhuangdao, Hebei, 066000, China
Contact Person: XueYong Li, Quality Manager
CorrespondentMs. Diana Hong / Mr. Tarzan. Wang
Shanghai Mid-Link Business Consulting Co., Ltd
Suite 5D, No.19, Lane 999, Zhongshan Road (S-2), Shanghai, 200030, China
T: +86-21-64684973;
F: 240-238-7587
Tarzan.wang@mid-link.net
Proposed DevicePatient Monitors, CMS8000
Common NamePatient Monitor
ClassificationMonitor, Physiological, Patient , MHX , 21 CFR 870.1025
PanelCardiovascular
Subsequent CodeDSI, MLD, DRT, DXN, DSK, DQA, BZQ, CCK, FLL
Device DescriptionThe proposed device, CMS8000 Patient Monitor is intended to be used for monitoring, displaying, reviewing, storing and alarming of multiple physiological parameters. It has the physical and technical alarming function with audio and visual alarming, The device can driven by AC or DC power supply.
Technological
CharacteristicsThe proposed device, CMS8000 Patient Monitor has no any new technological characteristics, all function and technological characteristic are same or similar as the predicate device.
Intended UseThe CMS8000 Patient Monitor is intended to be used for monitoring, displaying, reviewing, storing and alarming of multiple physiological parameters including ECG, Heart Rate (HR), Respiration Rate (RESP), Non-invasive Blood Pressure (NIBP), Invasive Blood Pressure (IBP), carbon dioxide (CO2), and Temperature (TEMP) of adult, pediatric and neonatal patient. The Pulse Oxygen Saturation (SpO2) and Pulse Rate (PR) are intended use for adult and pediatric

III-I

.

1

10 1692 7/2

.

Premarket Notification
Section 510(k) Submission
Section III 510(k) Submission
III 510(k) Summary

patient.
The monitor is to be used in healthcare facilities by clinical physicians or appropriate medical staff
under the direction of physicians. It is not intended for helicopter transport or hospital ambulance.
TestingPerformance testing including clinical and bench testing was conducted to validate and verify that
the proposed device, the Patient Monitors met all design specifications.
Clinical DiscussionThe proposed device, General Patient Monitors, has conducted clinical test into performance
verification of SpO2 and NIBP measure function according with the standard of ISO 9919 and
AAMI SP10.
Non Clinical DiscussionThe proposed device, General Patient Monitors, has conducted the test according with the
following standard to demonstrate the effectiveness and safety performance of device.
IEC 60601-1, Medical Electrical Equipment - Part 1: General Requirements for Safety, 1988;
Amendment 1, 1991-11, Amendment 2, 1995.
IEC 60601-1-2:2007 Medical Electrical Equipment - Part 1-2: General Requirements for Safety -
Collateral Standard: Electromagnetic Compatibility - Requirements and Tests.
AAMI / ANSI EC13:2002/(R) 2007, Cardiac monitors, heart rate meters, and alarms.
ISO 9919:2005: Medical electrical equipment - Particular requirements for the basic safety and
essential performance of pulse oximeter equipment for medical use.
AAMI SP10:2002, Manual, electronic or automated sphygmomanometers.
IEC 60601-2-34:2000, Medical electrical equipment - Part 2-34: Particular requirements for the
safety, including essential performance, of invasive blood pressure monitoring equipment.
ISO 21647:2004, Medical electrical equipment - Particular requirements for the basic safety and
essential performance of respiratory gas monitors.
SE ConclusionThe proposed device, General Patient Monitors, is Substantially Equivalent (SE) to the Predicate
Device, PM-7000 Patient Monitor, K072346

. . . .

.

·

2

DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized eagle with three stripes forming its wing and tail feathers. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" are arranged in a circular pattern around the eagle.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002

Contect Medical System Co., Ltd. c/o Diana Hong Suite 8D , Zhongxin Zhongshan Mansion, NO. 19, Lane 999, Zhong Shan, Shanghai China 200030

JUN 2 8 2011

Re: K101692

Trade/Device Name: CMS8000 Patient Monitor Regulation Number: 21 CFR 870.1025 Regulation Name: Patient Physiological Monitor (with arrhythmia detection and alarms) Regulatory Class: Class II (two) Product Code: MHX, DSI, MLD, DRT, DXN, DSK, DQA, BZQ, CCK, FLL Dated: June 14, 2011 Received: June 15, 2011

Dear Ms. Hong:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

3

Page 2 - Ms. Hong

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

Bram D. Zuckerman, M.D. 601 Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

4

Premarket Notification Section 510(k) Submission Section II Indication for Use Statement

Section II Indication for Use Statement

510(k) Number: Device Name: Patient Monitor Model: CMS8000

Indications for Use:

The CMS8000 Patient Monitor is intended to be used for monitoring, reviewing, storing and alaming of multiple physiological parameters including ECG, Heart Rate (HR), Respiration Rate (RESP), Non-invasive Blood Pressure (NIBP), Invasive Blood Pressure (IBP), cation dioxide (CO2), and Temperature (TEMP) of adult, pediatric and neonatal patient.

The Pulse Oxygen Saturation (SpO2) and Pulse Rate (PR) are intended use for adult and pediatric patient. The monitor is to be used in healthcare facilities by clinical physicians or appropriate medical staff under the direction of physicians. It is not intended for helicopter transport or hospital ambulance.

Prescription Use (Part 21 CFR 801 Subpart D)

AND/OR

Over-The-Counter Use (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEBDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)
Page 1 of
(Division Sign-Off)
Division of Cardiovascular Devices
510(k) Numberk10106

II-I